The doctors created the "neobladder" to replace Tom Ramsey's original bladder after it was destroyed by bladder cancer, in today's bite-sized hospital and health industry news from Florida, Minnesota, Texas, and Utah.
- Florida/Minnesota: Mayo Clinic and Leidos have announced they're collaborating to create an accelerator to help Mayo Clinic identify, create, and commercialize products and solutions. The accelerator, which will be located on Mayo's Life Sciences Incubator campus in Jacksonville, Florida, aims to assist patients and providers with "the most complex health care challenges," Kent Thielen CEO of Mayo Clinic in Florida said in a statement. The new accelerator also will help Leidos leverage its public health applications and systems integration solutions (Dietsche, MedCity News, 2/10).
- Texas: The Houston Health Department on Saturday announced that seven adult detainees at a U.S. Immigration and Customs Enforcement detention facility in Houston had been diagnosed with mumps, which is highly contagious. According to David Persse, medical director of the city's local health authority and emergency medical services, the outbreak is contained and does not pose an immediate threat to the community (Jackson, Reuters, 2/9).
- Utah: Doctors used a man's intestine to create a "neobladder" after his original organ was destroyed by bladder cancer. To create the neobladder, doctors took a segment of bowel from the small intestine, "reconfigure[d] it into a reservoir, and hook[ed] it down to where the bladder used to be," according to Chris Dechet, co-director of the Multidisciplinary Urologic Oncology Group at the Huntsman Cancer Institute. Ramsey said he is "back to normal" and has resumed his regular activities (Simonsen, KSL, 2/10).
Get the latest surgery market trends for 2019
Increasingly, general surgery leaders will be tasked with evolving their planning efforts, in response to minimally invasive technology innovations, payer pressures, and a continued shift toward outpatient care.
Join our experts on Tuesday, March 12 at 1 pm ET where we'll review these and other market trends impacting the general surgery service line and summarize's tactics necessary for growth in the upcoming year.